(Q45717902)

English

Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.

scientific article published on 31 August 2013

In more languages
default for all languages
No label defined

No description defined

Statements

Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit